The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection

This study has been terminated.

Sponsor:

ICN Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00002298

First Posted: August 31, 2001

Last Update Posted: December 9, 2005

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.